Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
Taiwan · Delayed Price · Currency is TWD 76.60
-0.40 (-0.52%)
Apr 17, 2026, 1:30 PM CST
Foresee Pharmaceuticals Market Cap
Foresee Pharmaceuticals has a market cap or net worth of 12.07 billion as of April 17, 2026. Its market cap has decreased by -6.07% in one year.
Market Cap
12.07B
Enterprise Value
11.82B
Revenue
431.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
76.60
Market Cap Chart
Since April 12, 2016, Foresee Pharmaceuticals's market cap has increased from 7.35B to 12.07B, an increase of 64.16%. That is a compound annual growth rate of 5.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 12.07B | -4.97% |
| Dec 31, 2025 | 12.70B | 5.86% |
| Dec 31, 2024 | 12.00B | -8.16% |
| Dec 29, 2023 | 13.06B | 20.98% |
| Dec 30, 2022 | 10.80B | -23.14% |
| Dec 30, 2021 | 14.05B | 34.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TTY Biopharm Company | 18.55B |
| Grape King Bio | 17.55B |
| ScinoPharm Taiwan | 17.32B |
| Synmosa Biopharma | 16.06B |
| YungShin Global Holding | 14.76B |
| Handa Pharmaceuticals | 13.36B |
| Standard Chemical & Pharmaceutical | 11.26B |
| Alar Pharmaceuticals | 11.22B |